2
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
4
CNS
4
Thoracic
3
Gastrointestinal
3
Classical hematology
3
Head & Neck
2
Gynecologic
2
Genitourinary
2
Dermatologic
2
Plasma cell
1
Other solid neoplasm
1
Lymphoid
1
Endocrine
1
Breast
1
Conditions
Lymphoma
2984
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2500
Lymphoma, Non-Hodgkin
2269
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1851
Lymphoma, Large B-Cell, Diffuse
1786
Leukemia
1341
Hodgkin Disease
1293
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
979
Burkitt Lymphoma
958
Multiple Myeloma
867
Lymphoma, B-Cell, Marginal Zone
854
Recurrence
842
Lymphoma, B-Cell
756
Myelodysplastic Syndromes
683
Neoplasms
595
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
415
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
352
Hematologic Neoplasms
352
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Amyotrophic Lateral Sclerosis
×
Lymphoid
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled